Gamma Medica Inc. has closed a $16 million Series A financing round from healthcare investment firm Psilos Group Managers, LLC. This investment will enable Gamma Medica to expand commercialization of the LumaGEM Molecular Breast Imaging (MBI) system and its companion product the LumaGUIDE MBI-guided biopsy module.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now